| John A Lyon, LCSW | |
|
2701 12th Ave S, Fargo, ND 58103-8753 | |
| (701) 451-4900 | |
| (651) 925-0057 |
| Full Name | John A Lyon |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 18 Years |
| Location | 2701 12th Ave S, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316121189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 4055 (North Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ellie Family Services Pllp | 8325309669 | 89 |
News Archive
A new study has detailed how some of the genes in the human genome inherited from Neanderthals appear to confer a protective effect against severe COVID-19.
Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Company's second-generation proteasome inhibitor. An intravenous formulation of MLN9708 entered clinical trials in March.
Individuals who are genetically predisposed to obesity may soon have a therapeutic solution to combat their condition. A research team led by scientists from the National University of Singapore (NUS) has identified several potent inhibitors that selectively target FTO, the common fat mass and obesity-associated gene.
AGA Medical Holdings, Inc. (AGA Medical) today announced the completion of the first phase of a litigation between AGA Medical and Medtronic, Inc., in which a California jury returned a verdict that some of AGA Medical's products infringed some of the claims of patents held by Medtronic, and that these patents have not been proven invalid over prior art.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEMs), today announced that new clinical data from the Phase 1 study of AG-221, an orally available, selective, potent inhibitor of the mutated IDH2 protein, will be highlighted in an oral presentation at the 19th Congress of the European Hematology Association (EHA) taking place June 12 -15, 2014 in Milan, Italy.
› Verified 9 days ago
| Entity Name | Ellie Family Services Pllp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740664150 PECOS PAC ID: 8325309669 Enrollment ID: O20180228001972 |
News Archive
A new study has detailed how some of the genes in the human genome inherited from Neanderthals appear to confer a protective effect against severe COVID-19.
Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Company's second-generation proteasome inhibitor. An intravenous formulation of MLN9708 entered clinical trials in March.
Individuals who are genetically predisposed to obesity may soon have a therapeutic solution to combat their condition. A research team led by scientists from the National University of Singapore (NUS) has identified several potent inhibitors that selectively target FTO, the common fat mass and obesity-associated gene.
AGA Medical Holdings, Inc. (AGA Medical) today announced the completion of the first phase of a litigation between AGA Medical and Medtronic, Inc., in which a California jury returned a verdict that some of AGA Medical's products infringed some of the claims of patents held by Medtronic, and that these patents have not been proven invalid over prior art.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEMs), today announced that new clinical data from the Phase 1 study of AG-221, an orally available, selective, potent inhibitor of the mutated IDH2 protein, will be highlighted in an oral presentation at the 19th Congress of the European Hematology Association (EHA) taking place June 12 -15, 2014 in Milan, Italy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John A Lyon, LCSW 1201 25th St S, Po Box 9859, Fargo, ND 58103-2311 Ph: (701) 451-4900 | John A Lyon, LCSW 2701 12th Ave S, Fargo, ND 58103-8753 Ph: (701) 451-4900 |
News Archive
A new study has detailed how some of the genes in the human genome inherited from Neanderthals appear to confer a protective effect against severe COVID-19.
Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Company's second-generation proteasome inhibitor. An intravenous formulation of MLN9708 entered clinical trials in March.
Individuals who are genetically predisposed to obesity may soon have a therapeutic solution to combat their condition. A research team led by scientists from the National University of Singapore (NUS) has identified several potent inhibitors that selectively target FTO, the common fat mass and obesity-associated gene.
AGA Medical Holdings, Inc. (AGA Medical) today announced the completion of the first phase of a litigation between AGA Medical and Medtronic, Inc., in which a California jury returned a verdict that some of AGA Medical's products infringed some of the claims of patents held by Medtronic, and that these patents have not been proven invalid over prior art.
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEMs), today announced that new clinical data from the Phase 1 study of AG-221, an orally available, selective, potent inhibitor of the mutated IDH2 protein, will be highlighted in an oral presentation at the 19th Congress of the European Hematology Association (EHA) taking place June 12 -15, 2014 in Milan, Italy.
› Verified 9 days ago
Rachel Marsolek, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 721 1st Ave N, Fargo, ND 58102 Phone: 701-461-7364 | |
Brittany Joy Alexander, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2101 Elm St N, Fargo, ND 58102 Phone: 701-232-3241 | |
Tracy E Mohn, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 4th St S, Fargo, ND 58103 Phone: 701-234-3106 Fax: 701-234-3106 | |
Rachel Salquist, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2101 Elm St N, Fargo, ND 58102 Phone: 701-232-3241 | |
Tracy M Foldesi-penas, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 4th St S, Fargo, ND 58103 Phone: 701-234-3100 Fax: 701-234-3120 | |
Lindsey Leigh Krueger, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 6046 14th St S, Fargo, ND 58104 Phone: 701-404-0997 Fax: 701-566-8876 | |
Deonne J Varriano, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2624 9th Ave S, Fargo, ND 58103 Phone: 701-298-4500 Fax: 701-298-4400 |